Loading data
NRXPNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.2 m USD | 0 USD | — | — | — |
| Cost of revenue | 505 k USD | 0 USD | — | — | — |
| Research and development expense | 3.78 m USD | 6.2 m USD | 13.37 m USD | 17.03 m USD | 20.26 m USD |
| Selling, general and administrative expense | 13.06 m USD | 13.5 m USD | — | — | — |
| Operating profit | -16.22 m USD | -18.5 m USD | -27.84 m USD | -44.34 m USD | -115.8 m USD |
| Interest expense | — | — | 120 k USD | — | 18 k USD |
| Profit before tax | — | — | — | -39.75 m USD | -93.06 m USD |
| Income tax expense | 0 USD | 0 USD | 0 USD | — | — |
| Net income (reported basis) | -28.6 m USD | -25.13 m USD | -30.15 m USD | -39.75 m USD | -93.06 m USD |
| Net income attributable to common shareholders | — | -25.13 m USD | -30.16 m USD | -39.75 m USD | -348.89 m USD |
| Basic earnings per share | -1.34 USD/share | -2.36 USD/share | -3.98 USD/share | -0.6 USD/share | -1.98 USD/share |
| Diluted earnings per share | — | — | — | -0.6 USD/share | -1.98 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.